The global apheresis market is projected to grow from $3.02 billion in 2026 to $4.41 billion by 2031, at a CAGR of 7.9%. Growth is fueled by rising autoimmune, neurological, and hematological diseases, increased demand for plasma-based therapies, and advances in automated apheresis technologies. North America leads the market due to its strong healthcare infrastructure and high demand for blood components. Challenges include high costs and limited donor availability, but expanding use in emerging markets and new therapies offer growth opportunities.
United Rentals reported strong Q2 2026 results with adjusted earnings of $12.76 per share and revenues of $4.41 billion, both surpassing analyst expectations. The company saw a 12.7% rise in rental revenues, driven by high demand, especially in speci...
Maison Solutions Inc. performed a 1-for-5 reverse stock split to meet Nasdaq's minimum bid price after its shares dropped significantly. The company is selling two unprofitable California stores to focus on its stronger Arizona locations, which gener...
Booz Allen Hamilton reported a strong quarterly earnings per share (EPS) of $1.81, surpassing analyst expectations of $1.49 by over 21%. However, its revenue slightly missed estimates at $2.80 billion, down from $2.92 billion a year ago. Despite the ...
The global automotive head-up display (HUD) market is forecasted to grow from $2.41 billion in 2026 to $4.71 billion by 2033, at a 10.1% CAGR. Growth is fueled by rising demand for driver safety, reduced distraction, and real-time vehicle info displa...
ALPHEA secured $5 million in strategic funding to accelerate development of its AI-native distributed operating environment designed for autonomous AI agents. The platform aims to support continuous AI agent operations with efficient execution, stora...
